KFAS
IRON icon

Keating Financial Advisory Services’s Disc Medicine IRON Stock Holding History

Keating Financial Advisory Services’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439 Buy
6
+3
+100% +$206 ﹤0.01% 2358
2026
Q1 		$192 Buy
+3
New +$208 ﹤0.01% 2376

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Keating Financial Advisory Services's IRON Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Disc Medicine (IRON) stake by 100% in Q2 2026, buying an estimated $206 and bringing the position to 6 shares worth $439. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

Keating Financial Advisory Services first reported a position in IRON in Q1 2026 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Keating Financial Advisory Services held 6 shares of Disc Medicine worth $439 as of Q2 2026.
  • Keating Financial Advisory Services bought 3 Disc Medicine shares in Q2 2026, an estimated $206.
  • Disc Medicine made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2358 holding.
  • Keating Financial Advisory Services first reported a position in Disc Medicine in Q1 2026 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.